Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 5/20 | 0.47 |
| ▸ | CA1 | P00915 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 7/20 | 0.43 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | STK17B | O94768 | 1/20 | 0.40 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21070201 | 0.83 | DRD2 (0.43) | CA12CA1CA2CA9TDP1 | |
| SCHEMBL34474799 | 0.82 | TDP1 (0.47) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL21071078 | 0.79 | CA1 (0.46) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL19027921 | 0.78 | CA1 (0.44) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL30803496 | 0.78 | ALDH1A1 (0.48) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL21069415 | 0.77 | TDP1 (0.47) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL2878788 | 0.75 | CA1 (0.44) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL5528585 | 0.74 | MAOA (0.48) | MAOAMAOBCA12CA1CA2 | |
| SCHEMBL3530338 | 0.74 | TBXAS1 (0.54) | TDP1 | |
| SCHEMBL31421606 | 0.74 | TBXAS1 (0.54) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8518859-B2 | Method for increasing yield of staple food crop | NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY (JP) | 2013-08-27 | — | — | US | disclosed |
| US-8518859-B2 | Method for increasing yield of staple food crop | NATIONAL UNIVERSITY CORPORATION SHIZUOKA UNIVERSITY (JP) | 2013-08-27 | — | — | US | disclosed |
| US-20120122690-A1 | Method For Increasing Yield Of Staple Food Crop | NATIONAL UNIVERSITY CORPORATION SHIZUOKA (JP) | 2012-05-17 | — | — | US | disclosed |
| US-20120122690-A1 | Method For Increasing Yield Of Staple Food Crop | NATIONAL UNIVERSITY CORPORATION SHIZUOKA (JP) | 2012-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122690-A1 | Method For Increasing Yield Of Staple Food Crop | SI, H1-0, H1-3 | MAOA 4193/4885MAOB 3721/4885CA12 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.